RBC Capital Reiterates Outperform on Johnson & Johnson, Maintains $175 Price Target
Johnson & Johnson (JNJ) Gets a Buy From RBC Capital
Morgan Stanley Adjusts Price Target on Johnson & Johnson to $169 From $167, Maintains Equalweight Rating
Johnson & Johnson Analyst Ratings
Stifel Raises Johnson & Johnson's Price Target to $160 From $155
Hold Rating Maintained Amid Johnson & Johnson Acquisition and Foreign Exchange Concerns
Stifel Nicolaus Remains a Hold on Johnson & Johnson (JNJ)
Johnson & Johnson Analyst Ratings
Johnson & Johnson Analyst Ratings
Johnson & Johnson Analyst Ratings
Johnson & Johnson Analyst Ratings
Halozyme Downgraded at Piper Sandler Despite Guidance Raise
Citigroup Adjusts Price Target on Johnson & Johnson to $180 From $185, Keeps Buy Rating
Johnson & Johnson Analyst Ratings
Johnson & Johnson Analyst Ratings
Citi Keeps Their Buy Rating on Johnson & Johnson (JNJ)
Johnson & Johnson Analyst Ratings
Johnson & Johnson (JNJ) Receives a Buy From RBC Capital
Johnson & Johnson Analyst Ratings
Redburn Atlantic Adjusts Johnson & Johnson Price Target to $160 From $170